Gore J., Silver R.. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis. Annals of the Rheumatic Diseases 2005; 64 (9):1387-1387.
Gorres B., Hollis B., Binkley T., Beare T., Specker B.. Low vitamin D status in rural and older populations with high body fat. FASEB JOURNAL 2005; 19 (4):A59-A59.
Govindan R., Kratzke R. A., Herndon J. E., Niehans G. A., Vollmer R., Watson D., Green M. R., Kindler H. L.. Gefitinib in patients with malignant mesothelioma: A phase II study by the Cancer and Leukemia Group B. CLINICAL CANCER RESEARCH 2005; 11 (6):2300-2304.
Graham E. M., Bradley S. M., Atz A. M.. Preoperative management of hypoplastic left heart syndrome. Expert Opinion on Pharmacotherapy 2005; 6 (5):687-693.
Graham E. M., Bradley S. M., Atz A. M.. Preoperative management of hypoplastic left heart syndrome. Expert Opinion on Pharmacotherapy 2005; 6 (5):687-93.
Graham E. M., Forbus G. A., Bradley S. M., Shirali G. S., Atz A. M.. Incidence and outcome of cardiopulmonary resuscitation in shunted single ventricle patients: Advantage of right ventricle to pulmonary artery shunt. Circulation 2005; 112 (17):U1193-U1193.
Granholm Ann-Charlotte, Bachman David, Mintzer Jacobo, Sambamurti Kumar. Commentary: "Ceramide and cholesterol: Possible connections between normal aging of the brain and Alzheimer's disease. Just hypotheses or molecular pathways to be identified?" by Claudio Costantini, Rekha M.K. Kolasani, Luigi Puglielli. Alzheimer's and Dementia 2005; 1 (1):53-54.
Granholm Ann-Charlotte, Bachman David, Mintzer Jacobo, Sambamurti Kumar. Commentary: "Ceramide and cholesterol: Possible connections between normal aging of the brain and Alzheimer's disease. Just hypotheses or molecular pathways to be identified?" by Claudio Costantini, Rekha M.K. Kolasani, Luigi Puglielli. Alzheimer's and Dementia 2005; 1 (1):53-4.
Granholm-Bentley L., Sambamurti K., Moore A., Bimonte-Nelson H.. Memory impairment in middle-aged rats on a high fat/high cholesterol. International Psychogeriatrics 2005; 17 ():100-100.
Grant S., Sullivan D., Roodman D., Stuart R., Perkins E. B., Ramakrishnan V., Wright J., Dimitrios Colevas A., Roberts J. D.. Phase I trial of Bortezomib (NSC 681239) and flavopiridol (NSC 649890) in patients with recurrent or refractory indolent B-cell neoplasms. Blood 2005; 106 (11):933A-933A.
Graves K. D., Carter C. L.. Outcome expectations and self-regulation in cancer patients: reliability, initial factor structure, and relationships with benefit finding. Palliative and Supportive Care 2005; 3 (3):209-19.
Graves K. D., Carter C. L.. Outcome expectations and self-regulation in cancer patients: reliability, initial factor structure, and relationships with benefit finding. Palliative and Supportive Care 2005; 3 (3):209-19.
Grdina D. J., Murley J. S., Kataoka Y., Zhou D., Seed T. M.. Radioprotectors: Current status and new directions. RADIATION RESEARCH 2005; 163 (6):704-705.
Green M. R.. The Laskin/Sandler article reviewed. Oncology-New York 2005; 19 (13):1678-1679.
Greenberg Benjamin D., Nahas Ziad, Carpenter Linda L.. Current status of deep brain stimulation. Primary Psychiatry 2005; 12 (10):59-64.
Gregory M., Kalivas P.. Effects of environmental enrichment and impoverishment on metabotropic glutamate receptors in the prefrontal cortex. Neuropharmacology 2005; 49 ():247-247.
Greig N. H., Utsuki T., Ingram D. K., Wang Y., Pepeu G., Scali C., Yu Q. S., Mamczarz J., Holloway H. W., Giordano T., Chen D. M., Furukawa K., Sambamurti K., Brossi A., Lahiri D. K.. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent. Proceedings of the National Academy of Sciences of the United States of America 2005; 102 (47):17213-17218.
Greig Nigel H., Sambamurti Kumar, Yu Qian-sheng, Brossi Arnold, Bruinsma Gosse B., Lahiri Debomoy K.. An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer's disease. Current Alzheimer Research 2005; 2 (3):281-290.
Griffin W. C., Skinner H. D., Birkle D. L.. Prenatal stress influences 8-OH-DPAT modulated startle responding and [H-3]-8-OH-DPAT binding in rats. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR 2005; 81 (3):601-607.
Gross P. S.. Functional genomics approaches to understanding stress responses and disease in shrimp. Integrative and Comparative Biology 2005; 45 (6):1005-1005.
Gross R. H.. Limb lengthening for stature: Another view. Journal of Pediatric Orthopaedics 2005; 25 (1):128-129.
Gross R. H.. Limb lengthening for stature: another view.[comment]. Journal of Pediatric Orthopedics 2005; 25 (1):128-9.
Grubaugh A. L., Frueh B., Magruder K. M.. Do research participants who decline to answer sexual trauma questions differ from those who do not?. American Journal of Psychiatry 2005; 162 ():1757-1758.
Grubaugh A. L., Magruder K. M., Waldrop A. E., Elhai J. D., Knapp R. G., Frueh B. C.. Subthreshold PTSD in primary care - Prevalence, psychiatric disorders, healthcare use, and functional status. Journal of Nervous and Mental Disease 2005; 193 (10):658-664.
Grubaugh A. L., Magruder K. M., Waldrop A. E., Elhai J. D., Knapp R. G., Frueh B. C.. Subthreshold PTSD in primary care: prevalence, psychiatric disorders, healthcare use, and functional status. Journal of Nervous and Mental Disease 2005; 193 (10):658-64.
Grubaugh A. L., Magruder K. M., Waldrop A. R., Elhai J. D., Knapp R. G., Frueh B. C.. Subthreshold PTSD in primary care: Prevalence, psychiatric disorders, healthcare use, and functional status. Journal of Nervous and Mental Disease 2005; 27 (3):169-179.
Grund E. M., Muise-Helmericks R. C.. Cost efficient and effective gene transfer into the human natural killer cell line, NK92. Journal of Immunological Methods 2005; 296 (1-2):31-36.
Grund E. M., Muise-Helmericks R. C.. Cost efficient and effective gene transfer into the human natural killer cell line, NK92. Journal of Immunological Methods 2005; 296 (1-2):31-6.
Grund E. M., Spyropoulos D. D., Watson D. K., Muise-Helmericks R. C.. Interleukins 2 and 15 regulate Ets1 expression via ERK1/2 and MNK1 in human natural killer cells. Journal of Biological Chemistry 2005; 280 (6):4772-4778.
Grund E. M., Spyropoulos D. D., Watson D. K., Muise-Helmericks R. C.. Interleukins 2 and 15 regulate Ets1 expression via ERK1/2 and MNK1 in human natural killer cells. Journal of Biological Chemistry 2005; 280 (6):4772-8.
Grush Owen C.. Review of Women's Mental Health: A Comprehensive Text. Annals of Clinical Psychiatry 2005; 17 (1):53-54.
Grush Owen C.. Review of Feeling Good: The Science of Well-Being. Annals of Clinical Psychiatry 2005; 17 (1):52-53.
Gueldner S. H., Michel Y., Bramlett M. H., Liu C. F., Johnston L. W., Endo E., Minegishi H., Carlyle M. S.. The well-being picture scale: A revision of the index of field energy. Nursing Science Quarterly 2005; 18 (1):42-50.
Guichard J. L., Wong R. P., Beeson C. C.. High density lipoprotein and its role in coupling mitochondrial respiration and glycolysis. FASEB JOURNAL 2005; 19 (4):A830-A830.
Guimaraes M., Uflacker R., Schonholz C., Hannegan C., Selby J. B.. Stent migration complicating treatment of inferior vena cava stenosis after orthotopic liver transplantation. Journal of Vascular and Interventional Radiology 2005; 16 (9):1247-52.
Guimaraes P., Kieburtz K., Goetz C. G., Elm J. J., Palesch Y. Y., Huang P., Ravina B., Tanner C. M., Tilley B. C.. Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials. Clinical Trials 2005; 2 (6):509-518.
Guimaraes P., Kieburtz K., Goetz C. G., Elm J. J., Palesch Y. Y., Huang P., Ravina B., Tanner C. M., Tilley B. C.. Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials. Clinical Trials 2005; 2 (6):509-18.
Guirgis Gamil A., Horn Anne, Klaeboe Peter, Nielsen Claus J.. Vibrational spectroscopic studies, conformations and ab initio calculations of 3,3,3-trifluoropropyltrichlorosilane. Spectrochimica Acta Part A, Molecular and Biomolecular Spectroscopy 2005; 61 (7):1335-1346.
Guo L., Dominguez N., Dozmorov I., Tang Y. H., Namjou B., Kelly J., Hutchings D., Bruner G., Klein W., James J. A., Kaufman K., Scofield H., Kamen D., Gilkeson G., Guthridge J. M., Harley J. B.. Analysis of gene expression in EBV-transformed B cells from lupus patients. FASEB JOURNAL 2005; 19 (4):A350-A350.
Gupta R. P., He Y. A., Patrick K. S., Halpert J. R., Bell N. H.. CYP3A4 is a vitamin D-24- and 25-hydroxylase: Analysis of structure function by site-directed mutagenesis. Journal of Clinical Endocrinology and Metabolism 2005; 90 (2):1210-1219.
Gupta R. P., He Y. A., Patrick K. S., Halpert J. R., Bell N. H.. CYP3A4 is a vitamin D-24- and 25-hydroxylase: analysis of structure function by site-directed mutagenesis. Journal of Clinical Endocrinology and Metabolism 2005; 90 (2):1210-9.
Gustafson K. K., Darden P. M.. Are racial disparities in immunization rates due to reduced access to care?. Journal of Investigative Medicine 2005; 53 (1):S324-S324.
Guyton M. K., Sribnick E. A., Ray S. K., Banik N. L.. A role for calpain in optic neuritis. In: , editor. Neuroprotective Agents. : , 2005. p. 48-54.
Guyton M. K., Sribnick E. A., Ray S. K., Banik N. L.. A role for calpain in optic neuritis. Annals of the New York Academy of Sciences 2005; 1053 ():48-54.
Guyton M. Kelly, Wingrave J. Michael, Yallapragada Anil V., Wilford Gloria G., Sribnick Eric A., Matzelle Denise D., Tyor William R., Ray Swapan K., Banik Naren L.. Upregulation of calpain correlates with increased neurodegeneration in acute experimental auto-immune encephalomyelitis. Journal of Neuroscience Research 2005; 81 (1):53-61.
Hadden M. K., Orwig K. S., Kokko K. P., Mazella J., Dix T. A.. Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues. Neuropharmacology 2005; 49 (8):1149-1159.
Hadden M. K., Orwig K. S., Kokko K. P., Mazella J., Dix T. A.. Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues. Neuropharmacology 2005; 49 (8):1149-59.
Hadden M. K., Walle T., Dix T. A.. Cellular uptake of a radiolabelled analogue of neurotensin in the Caco-2 cell model. Journal of Pharmacy and Pharmacology 2005; 57 (3):327-333.
Hadden M. Kyle, Walle Thomas, Dix Thomas A.. Cellular uptake of a radiolabelled analogue of neurotensin in the Caco-2 cell model. Journal of Pharmacy and Pharmacology 2005; 57 (3):327-33.
Hadden M., Orwig Kevin S., Kokko Kyle P., Mazella Jean, Dix Thomas A.. Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues. Neuropharmacology 2005; 49 (8):1149-1159.